http://orcid.org/0000-0003-3707-0582
Figures
Abstract
Objective
The objective of this review is to evaluate the existing evidence about the knowledge, attitude, and perceptions (KAP) of healthcare students towards pharmacovigilance and adverse drug reactions reporting (ADRs).
Methods
A systematic literature search was conducted using MEDLINE, CINAHL, EMBASE, ERIC, and Cochrane Database of Systematic Reviews via OVID. This review restricted the search to studies published in English from inception until December 2019.
Primary and secondary outcome measures
The primary outcome was healthcare students’ knowledge, attitude, and perceptions of pharmacovigilance.
Results
Of the 664 articles identified, twenty-nine studies were included in the review. Overall, healthcare students vary in their knowledge and attitude towards pharmacovigilance and ADRs reporting. There was inconsistency in measuring KAP between the studies and the main drawback in the literature is lacking validated KAP measures.
Citation: Alwhaibi M, Al Aloola NA (2020) Healthcare students' knowledge, attitude and perception of pharmacovigilance: A systematic review. PLoS ONE 15(5): e0233393. https://doi.org/10.1371/journal.pone.0233393
Editor: Lisa Susan Wieland, University of Maryland School of Medicine, UNITED STATES
Received: January 7, 2020; Accepted: May 4, 2020; Published: May 20, 2020
Copyright: © 2020 Alwhaibi, Al Aloola. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All data generated or analysed during this study are included in this published article.
Funding: This research project was supported by a grant from the “Research Center of the Center for Female Scientific and Medical Colleges”, Deanship of Scientific Research, King Saud University.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Pharmacovigilance is an important discipline worldwide to ensure patient safety and the appropriate use of medicines [1]. World Health Organization (WHO) defines pharmacovigilance (PV) as “the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem.”[2] Pharmacovigilance and adverse drug reactions (ADRs) reporting education are important competencies all healthcare school students need to obtain before they graduate and be involved in clinical practice as healthcare professionals [3]. Therefore, educating healthcare students in the school of medicine, pharmacy, dentistry, or nursing and involving them early in clinical practice to prescribe, administer, and/or monitor medications is essential to ensure the safe use of medications [4].
Healthcare students may not recognize the importance of post-marketing ADR and may not have received sufficient knowledge and skills to recognize and adequately report the ADRs during their education. Literature indicated that many healthcare students missed the training on this topic, and inadequately prepared during their education for their role in monitoring and reporting ADRs [3, 5]. In addition, previous studies have shown that pharmacy students have insufficient knowledge of pharmacovigilance and ADRs reporting [3, 5].
Unfamiliarity with pharmacovigilance and ADR-reporting have been associated with ADRs underreporting by healthcare professionals [6, 7]. Further, underreporting and the lack of understanding of ADRs could lead to a greater burden on patients, payers, and healthcare systems. Therefore, knowledge and perception toward the safety profile of medications are essential. Educating healthcare professionals on the possible existence of unexpected adverse reactions and how to report them to the local regulatory authorities can facilitate the detection and assessment of drug safety signals.
The purpose of this systematic review is to evaluate the literature that measures the level of healthcare students’ knowledge, attitude, and perception of pharmacovigilance and ADRs reporting. This can help to identify the current need for education/training on pharmacovigilance and the research need to improve our understanding of healthcare students’ knowledge, attitude, and perception of pharmacovigilance.
By summarizing the published literature in this area it should be possible to grasp a more understanding of the existing evidence and understand future needs for research in this area. Our review research questions are:
- What is known about healthcare students’ pharmacovigilance knowledge?
- What is known about healthcare students' attitudes and perceptions of pharmacovigilance?
- Are there any validated measures to assess students’ knowledge, attitude, and perception toward PV in the existing literature, and what could future studies add to our understanding of the healthcare students' knowledge, attitude and perception of pharmacovigilance?
Methods
Eligibility criteria
Study inclusion criteria were as follows: (1) study population consisting of healthcare students (medical, pharmacy, dental, and nursing) at any stage of their undergraduate training, (2) the study outcome is the knowledge, attitude or perception of pharmacovigilance, and (3) study design is cross-sectional.
Exclusion criteria were as follows (1) study population consisting of postgraduate or healthcare professionals, (2) qualitative study design, and (3) report language is non-English.
Search strategy
The present systematic review was reported according to the Preferred Reporting Items for the Systematic Reviews and Meta-Analyses (PRISMA) guidelines (S2 Appendix) [8].
Research articles were retrieved from six databases (MEDLINE via EBSCO, Cumulative Index to Nursing and Allied Health Literature (CINAHL®) via EBSCO, EMBASE, ERIC via EBSCO, and Cochrane Database of Systematic Reviews via OVID) with database-specific queries. These databases were searched using both controlled and free-text language. In terms of free-text search, the keywords included the following terms/combination of terms: (knowledge OR attitude OR perception) AND (healthcare students OR medical students OR pharmacy students OR dental) AND (pharmacovigilance OR adverse drug reactions reporting). For the controlled language search included the following exploded Medical Subject Headings (MeSH) terms: "knowledge”, “attitude”, “perception", "Students, Medical", "Students, Pharmacy", "Students, Nursing", "Students, Dental", "Pharmacovigilance" and " Drug-Related Side Effects and Adverse Reactions” as recommended for each databases. S1 Appendix shows the complete search strategy used in MEDLINE.
Articles search of the four databases was conducted independently by two review authors (MA and NA), any disagreement was resolved by consensus. Besides, bibliographies from the selected articles were searched manually for relevant articles. Limits that were applied included selecting studies published in English from inception until December 2019; studies pertaining to the evaluation of pharmacovigilance knowledge, attitude or perception and where the participants are healthcare students.
Study selection
At first, literature screening of the extracted articles involved examining the titles and abstracts for relevant articles for inclusion was conducted independently by two review authors (MA and NA). Then, the review authors evaluated the full-text articles against the inclusion/exclusion criteria. The article selection process resulted in twenty-nine studies included in this systematic review (Fig 1).
From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi: 10.1371/journal.pmed1000097 For more information, visit www.prisma-statement.org.
Data extraction and quality assessment
The two review authors (MA and NA) independently extracted the included data. Information about the study characteristics, methodological details, main outcome measures, and findings were extracted from the selected articles and organized in an excel table to facilitate the assessment of their quality using STROBE (Strengthening The Reporting of OBservational Studies in Epidemiology) checklist [9]. This tool covers twenty-two criteria for study design quality and biases in the study. For each criterion met, the study gets one point; the highest score indicates the highest quality of the study. Besides, we have used the five items risk of bias in cross-sectional surveys of attitudes and practice [10].
Results
Selection process
A total of 664 articles were identified from all searches, with 636 remaining after the removal of duplicates. Based on the title and abstract screening, 39 full-text articles were retrieved. Of these, twenty-two studies met the inclusion criteria and included in the final review (Fig 1).
General characteristics of included studies
The characteristics of the included studies are displayed in Table 1. Studies that evaluated pharmacovigilance knowledge, attitude or perception of healthcare students started to appear since 2011. The majority of the included studies involved pharmacy students [11–19], while few studies specifically focused on healthcare students [20–22], nursing students [23], and dental students [24, 25]. The total number of included studies was twenty-nine, with sample sizes ranging from 30 to 874. Response rates across the studies varied from 24% to 100%. Twenty-seven studies examined the Pharmacovigilance knowledge [11–35], twelve studies evaluated attitudes towards pharmacovigilance [14, 16, 19–21, 23–26, 29, 30, 33], and fourteen studies measured the perception of pharmacovigilance [11–15, 17, 18, 21–23, 26–28, 31, 36]. Around 50% of the included studies (n = 15) were pilot tested among the students that were not included in the final analysis. A pilot test was used to evaluate the validity and reliability of the instrument with an overall reliability coefficient, Cronbach’s alpha, ranging from 0.69–0.82 suggesting that the items included in these studies have relatively high internal consistency.
Quality assessment
Overall, the included studies scored well for clearly stating the study aims, design, target population, risk factors and outcomes measurement, result explanation, and discussion and conclusion justified by the results (Table 1). The main issues were mainly related to failure to address the sample size calculation or addressing the non-response rate. Besides, many studies have no information about the missing data within completed questionnaires and have not conducted pilot testing.
Main findings
Key information form selected articles were extracted and tabulated using the following categories: pharmacovigilance knowledge, attitude or perception (Table 1).
Pharmacovigilance knowledge
Knowledge about pharmacovigilance and ADR reporting was mainly evaluated using multiple-choice response options ranging from 10 to 15 questions [11, 12, 14–17, 19, 20, 23, 26, 29–35]. A score of 1 was given for each correct answer and 0 for each wrong answer. The most common questions asked about PV, ADR definitions and the local regulatory body of ADR reporting, while few studies asked about the ADR causality assessment, types of ADR, and the online WHO PV database (S3 Appendix). Generally, knowledge of healthcare students about the local regulatory body and local reporting system of ADR reporting was inadequate. One study conducted by Khan et al compared the knowledge between medical and pharmacy students and found that pharmacy students have a significantly higher knowledge of pharmacovigilance compared to medical students [26]. Another study by Sivadasan et al had also compared medical to pharmacy students and found that pharmacy students have better knowledge and perception towards pharmacovigilance and ADR reporting compared to medical students [12].
Pharmacovigilance attitude
Attitude towards pharmacovigilance and ADR reporting was measured using multiple-choice response options ranging from 2 to 5 questions [20, 30], and using a 5-point Likert scale [16, 24]. Although only a few studies evaluated attitude; it should be noted that some questions used were related to measuring the perception rather than attitude [16, 22, 26, 31]. The most commonly asked question was about the willingness of students to report any ADR in their future practice (S3 Appendix). The attitude towards PV and ADRs from the included studies ranged from 25% to 97% [16, 20, 24].
Pharmacovigilance perception
Perception about pharmacovigilance and ADR reporting was measured using a 5-point Likert-scale format (1 strongly agree to 5 strongly disagree) [11–13, 15, 17, 21, 23], questions range from 5 to 13 questions [11–13, 23, 31]. However, some studies evaluated perceptions using multiple-choice response options [14]. The majority of included studies evaluated perceptions by asking students about their belief of PV, i.e. if they think that PV should be included in the curriculum, if they think ADR reporting should be made compulsory, and if they are allowed or trained to perform ADR reporting during the clerkship (S3 Appendix). The perception regarding PV and ADRs from the included studies was ranging from 25% to 97% [11–13, 15, 17, 21, 23]. Khan et al compared the perceptions between medical and pharmacy students and found that pharmacy students reported more positive responses to all of the perceptions statements than the medical students (P<0.05) [26].
Discussion
The present systematic review identified the available literature that evaluated KAP of PV and ADR reporting of any healthcare school students. Most of the published studies evaluated KAP among pharmacy students, while few focused on medical, dental, and nursing students. A summary of different measures used to assess KAP among different healthcare students was provided in this review.
Our review highlights the main drawback in this area, which is the lack of standardized validated measures to assess knowledge, perception, and attitude toward PV and ADR reporting. There were variations in items used in different studies to assess KPA of students. The survey instruments were pilot tested in fifteen studies and the internal consistency measured using Cronbach’s Alpha. However; no item analysis in the form of difficulty and discrimination was reported in any of these studies.
Moreover, findings from this review highlight the variation in KAP of different healthcare students towards pharmacovigilance and ADRs reporting. This variation could be attributed to the following factors: i) inconsistency in tools/measured used to evaluate KAP between the studies; ii) lacking validated KAP measures, iii) different study setting, and iv) different PV and ADR reporting experiences during their education. Therefore developing a standard validated measure is needed to optimize KAP assessment.
Our knowledge findings are consistent with the previously published review, which investigates the pharmacovigilance competencies of all healthcare students [3]. Knowledge about PV is poor, despite the good perception about PV importance and the good attitude toward PV and ADR reporting. Based on Reumerman et al. review many factors could influence PV competencies such as; type of healthcare school, academic level of study and previous training [3]. This review shows that educational interventions such as; short lectures, workshops, training in ADR reporting and assessment have improved healthcare students’ knowledge, perception and positive attitude toward PV [3]. However, it is unknown which education intervention was the best to improve students’ PV knowledge and competences, due to variation in questions or outcomes scores that have been used by the authors.
In our review, students’ satisfaction towards PV coverage in their curriculum varied from 21 to 85%. This finding indicates variation in PV integration in the curriculum between different healthcare schools. Besides, the finding highlights the need for uniform PV educational intervention. Given the importance of PV and ADR reporting in preventing serious health problems, more education in the field of PV and ADRs is needed. Moreover, standards for teaching PV have been developed by experts working in different fields of medication safety worldwide in the World Health Organization (WHO and the International Society of Pharmacovigilance (ISoP). The WHO-ISoP group had created core elements of a comprehensive PV curriculum to guide the PV integration into the healthcare schools' curriculum [37]. Besides, Stakeholders’ initiated on behalf of the WHO an agreement about PV competencies and key aspects of subjects that should be taught with a focus on clinical Aspects [4]. The five main aspects that were identified include 1) understanding the importance of PV; 2) preventing; 3) recognizing; 4) managing and; 5) reporting ADRs. These competencies should be integrated into the curriculum of healthcare students to improve their knowledge about PV. This review has helped us gather evidence about the absence of standardized validated measure to evaluate the KAP of PV and ADR reporting of any healthcare school students. Our search strategy was comprehensive, including studies published in English, and a manual search of relevant studies. Besides, quality assessment was conducted to evaluate the quality of the design of the included studies and the presence of potential bias. The main limitation in our review is the heterogeneity of assessment measures used between different included studies, which made a meta-analysis impossible. However, this heterogeneity directs the future need for a standardized validated assessment measure and a unified PV educational intervention for healthcare students in different healthcare schools. Besides, many studies have no information about the missing data within completed questionnaires and have not conducted pilot testing. Another limitation was that the searches developed and carried out without collaboration with a trained information specialist.
Conclusions
This review demonstrated the lack of PV knowledge among healthcare students and identified several research gaps that need to be focused on future research. These include; developing a standard validated measure to assess students’ knowledge, attitude, and perception toward PV. Further, the development of a unified PV education intervention to adequately prepare our future healthcare providers to rationally report ADR of drugs is crucial.
Supporting information
S1 Appendix. Search strategy used in MEDLINE.
https://doi.org/10.1371/journal.pone.0233393.s001
(DOCX)
S3 Appendix. Questions used to measures knowledge, attitude, and perceptions of medical students in the included studies.
https://doi.org/10.1371/journal.pone.0233393.s003
(DOCX)
References
- 1. Kumar A. Pharmacovigilance: Importance, concepts, and processes. American Journal of Health-System Pharmacy. 2017;74(8):606–12. pmid:28235869
- 2.
World Health Organization. Pharmacovigilance. [cited 2019 20]; Available from: https://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/.
- 3. Reumerman M, Tichelaar J, Piersma B, Richir M, van Agtmael M. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. European journal of clinical pharmacology. 2018;74(10):1235–48. pmid:29926135
- 4. Van Eekeren R, Rolfes L, Koster AS, Magro L, Parthasarathi G, Al Ramimmy H, et al. What future healthcare professionals need to know about pharmacovigilance: introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects. Drug safety. 2018;41(11):1003–11. pmid:29949100
- 5. Smith MP, Webley SD. Pharmacovigilance teaching in UK undergraduate pharmacy programmes. Pharmacoepidemiology and Drug Safety. 2013;22(3):223–8. pmid:22745046
- 6. Varallo FR, Guimarães SdOP, Abjaude SAR, Mastroianni PdC. Causes for the underreporting of adverse drug events by health professionals: a systematic review. Revista da Escola de Enfermagem da USP. 2014;48(4):739–47.
- 7. Olsson S, Pal SN, Stergachis A, Couper M. Pharmacovigilance activities in 55 low-and middle-income countries. Drug safety. 2010;33(8):689–703. pmid:20635827
- 8. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine. 2009;6(7):e1000097. pmid:19621072
- 9. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Journal of Clinical Epidemiology. 2008;61(4):344–9. pmid:18313558
- 10. Guyatt G, Busse J. Methods commentary: Risk of bias in cross-sectional surveys of attitudes and practices.
- 11. Elkalmi RM, Hassali MA, Ibrahim MIM, Widodo RT, Efan QM, Hadi MA. Pharmacy students’ knowledge and perceptions about pharmacovigilance in Malaysian public universities. American journal of pharmaceutical education. 2011;75(5):96. pmid:21829270
- 12. Sivadasan S, Chyi N, Ching A, Ali A, Veerasamy R, Marimuthub K, et al. Knowledge and perception towards pharmacovigilance and adverse drug reaction reporting among medicine and pharmacy students. World J Pharm Pharm Sci. 2014;3(3):1652–76.
- 13. Sharma S, Sharma J, Aggarwal T. A survey on knowledge and perception of pharmacy students towards adverse drug reaction (ADR) reporting. Asian Journal of Pharmaceutical and Clinical Research. 2012;5:129–31.
- 14. Reddy VL, Pasha SJ, Rathinavelu M, Reddy YP. Assessment of knowledge, attitude and perception of pharmacovigilance and adverse drug reaction (ADR) reporting among the pharmacy students in south India. IOSR J Pharm Biol Sci. 2014;9(2):34–43.
- 15. Osemene KP, Afolabi MO. An evaluation of the knowledge and perceptions of pharmacy students on pharmacovigilance activities in Nigeria. BMC research notes. 2017;10(1):273. pmid:28697738
- 16. Alkayyal N, Cheema E, Hadi MA. Perspective of Saudi undergraduate pharmacy students on pharmacovigilance and adverse drug reaction reporting: A National Survey. Currents in Pharmacy Teaching and Learning. 2017;9(5):779–85. pmid:29233304
- 17. Shekaili N, Haridass S, Hassali M, Nouri A. Knowledge and Perceptions of Pharmacy Students about Pharmacovigilance in Oman. 2017;1.
- 18. Rajiah K, Maharajan MK, Nair S. Pharmacy students’ knowledge and perceptions about adverse drug reactions reporting and pharmacovigilance. Saudi Pharmaceutical Journal. 2016;24(5):600–4. pmid:27752233
- 19. Gavaza P, Bui B. Pharmacy students’ attitudes toward reporting serious adverse drug events. American journal of pharmaceutical education. 2012;76(10):194. pmid:23275659
- 20. Tadvi NA, Alromaih AA, Aldahash AA, Almuhesseny AA, Alotaibi SH, Alduhayshi IS, et al. Knowledge, Attitude and Practice of Pharmacovigilance in Healthcare Professionals and Medical Students in Majmaah, Saudi Arabia Care Centre. Health Sciences. 2018;7(4):101–7.
- 21. Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rissmann R, Kramers C, et al. Pharmacovigilance skills, knowledge and attitudes in our future doctors–A nationwide study in the Netherlands. Basic & clinical pharmacology & toxicology. 2017;120(5):475–81.
- 22. Abubakar AR, Chedi BA, Mohammed KG, Haque M. Perception of Nigerian medical students on adverse drug reaction reporting. Journal of advanced pharmaceutical technology & research. 2015;6(4):154.
- 23. Sivadasan S, Sellappan M. A study on the awareness and attitude towards pharmacovigilance and adverse drug reaction reporting among nursing students in a private university, Malaysia. Int J Curr Pharm Res. 2015;7(1):84–9.
- 24. Chhabra K, Sharma A, Chhabra C, Reddy J, Deolia S, Mittal Y. Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study. The journal of contemporary dental practice. 2017;18(10):964–9. pmid:28989138
- 25. Shalini S, Mohan S. Knowledge and attitude towards pharmacovigilance and adverse drug reaction reporting among dental students in a Private University, Malaysia. Journal of Young Pharmacists. 2015;7(2):118.
- 26. Khan MU, Ahmad A, Ejaz A, Rizvi SA, Sardar A, Hussain K, et al. Comparison of the knowledge, attitudes, and perception of barriers regarding adverse drug reaction reporting between pharmacy and medical students in Pakistan. Journal of educational evaluation for health professions. 2015;12.
- 27. Farha RA, Alsous M, Elayeh E, Hattab D. A cross-sectional study on knowledge and perceptions of pharmacovigilance among pharmacy students of selected tertiary institutions in Jordan. Tropical Journal of Pharmaceutical Research. 2015;14(10):1899–905.
- 28. Kothari N. An evaluation of knowledge and perception of pharmacy students toward pharmacovigilance and adverse drug event reporting. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm. 2015;9(4).
- 29. Marko S. A study of knowledge, attitude, and practice of pharmacovigilance among medical students at a tertiary care teaching hospital in Madhya Pradesh, India. National Journal of Physiology, Pharmacy and Pharmacology. 2019;9(9):851–5.
- 30. Gaude OS, De Sa S. Assessment of knowledge, attitude, and practices of pharmacovigilance and adverse drug reaction reporting among final year medical students-A questionnaire-based study in a tertiary care hospital in Goa. National Journal of Physiology, Pharmacy and Pharmacology. 2018;8(12):1657–61.
- 31. Ajantha HB, Kumar M. Knowledge, attitude, and practices regarding adverse drug reaction reporting among dental students. Drug Invention Today. 2018;10(6).
- 32. Yu YM, Kim S, Choi KH, Jeong KH, Lee E. Impact of knowledge, attitude and preceptor behaviour in pharmacovigilance education. Basic & clinical pharmacology & toxicology. 2019;124(5):591–9.
- 33. Katyal J, Arora E, Gupta YK. Impact of increased focus on pharmacovigilance on knowledge and attitude towards adverse drug reaction reporting among medical students in India. International Journal of Risk & Safety in Medicine. 2019(Preprint):1–10.
- 34. Khan S, Mirza AA, Aamir MU. Fourth and Final Year Pharmacy Students’ Knowledge about Adverse Drug Reaction Reporting and Pharmacovigilance in A Pharmacy College of Lahore. Cell. 2018;300:8470969.
- 35. Aamir MU, Mirza AA, Khan S, Anjum KM. Knowledge of Pharmacovigilance and Adverse Drug Reaction reporting of Pharmacy and Medical Students. Pakistan Journal of Medical and Health Sciences. 2018;12(3):1158–61.
- 36. Kalari S, Dormarunno M, Zvenigorodsky O, Mohan A. Pharmacy student perceptions of adverse event reporting. American journal of pharmaceutical education. 2011;75(7):131. pmid:21969717
- 37. Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug safety. 2014;37(10):743–59. pmid:25171836
- 38. Limaye D, Shah P, Shah A, Pillay R, Modak V, Chaudhari A, et al. A study to determine the knowledge of pharmacovigilance among pharmacy students from Mumbai university. 2018.
- 39. Othman GQ, Ibrahim MIM, Alshakka M, Ansari M, Al-Qadasi F, Halboup AM. Knowledge and Perception about Pharmacovigilance among Pharmacy Students of Universities in Sana’a Yemen. Journal of clinical and diagnostic research: JCDR. 2017;11(6):FC09. pmid:28764191
- 40. Jha N, Rathore DS, Shankar PR, Gyawali S. Pharmacovigilance knowledge among patients at a teaching hospital in Lalitpur district, Nepal. Journal of clinical and diagnostic research: JCDR. 2014;8(3):32. pmid:24783073